FCHO1

FCHO1 is an early-acting organizer of clathrin-mediated endocytosis that nucleates clathrin-coated pit formation by integrating membrane recognition with assembly of the endocytic initiation machinery (PMID:27237791, PMID:32098969). Through its μ-homology domain it serves as an interaction hub, decoding spacing-dependent DPF triads in Eps15/R, and together with Eps15/R and AP-2 it forms transient ternary nanoclusters in which the FCHO1 interdomain linker drives conformational activation of AP-2 to promote cargo engagement (PMID:27237791). The μ-homology domain also engages additional partners such as the BMP receptor Alk8, linking FCHO1 to receptor handling beyond a strictly compulsory coat-nucleation role (PMID:22484487). Loss-of-function mutations mislocalize FCHO1 or abolish partner binding and impair coated-pit formation; in T cells this manifests as severely defective TCR internalization that is restored by wild-type FCHO1, establishing FCHO1 as causative for a human immunodeficiency (PMID:32098969). The two functional modules are deployed in a demand-dependent manner: the F-BAR domain alone suffices for low endocytic load, whereas the μ-homology domain becomes essential under high endocytic demand, as shown for synaptic vesicle endocytosis (PMID:41943152). This cooperative initiation logic is conserved, with the yeast ortholog Syp1 acting with Yap1801/Yap1802 to assemble an Ede1 (Eps15)-centric initiation complex at anionic-lipid- and cargo-enriched membrane sites (PMID:39316607).

1. 2007 Low

   Whether FCHO1 dynamics are coupled to clathrin-coated vesicle formation was unknown; correlating its temporal behavior with clathrin established a candidate role in coated-pit cycling.

   Evidence Live-cell fluorescence imaging of GFP-FCHO1 with temporal correlation to clathrin dynamics in cultured cells

   PMID:17617719

   Open questions at the time

   • Correlation-based without functional manipulation
   • Does not define molecular partners or curvature role
   • Perinuclear localization not mechanistically explained
2. 2012 High

   It was unclear whether FCHO1 is an obligatory coat nucleator preceding AP-2; identifying the μ-homology domain as an interaction hub binding Alk8 and showing a milder phenotype than AP-2 loss reframed it as a non-compulsory organizer.

   Evidence Morpholino silencing in zebrafish with dorsoventral patterning readouts plus co-IP of the μ-homology domain with Alk8 and comparison to AP-2 knockdown

   PMID:22484487

   Open questions at the time

   • Alk8 interaction not extended to mammalian receptors
   • Does not resolve molecular ordering relative to AP-2 at single pits
   • In vivo phenotype is indirect readout of endocytic activity
3. 2016 High

   How FCHO1 coordinates Eps15/R and AP-2 was undefined; structural and cellular work showed it decodes spacing-dependent DPF triads, forms transient ternary nanoclusters, and conformationally activates AP-2 for cargo engagement.

   Evidence X-ray crystallography of the Eps15/R·Fcho1 μ-homology domain complex with FCHO1/2 knockout cell assays and structure-function mutagenesis

   PMID:27237791

   Open questions at the time

   • Stoichiometry and lifetime of nanoclusters in vivo not fully quantified
   • Linker-driven AP-2 activation mechanism not resolved at atomic level
4. 2020 High

   Whether FCHO1 is essential for cargo-specific endocytosis in human cells and disease was unknown; patient mutations impairing coated-pit formation and TCR internalization, rescued by wild-type, established a causative physiological role.

   Evidence Live-cell imaging of mutant variants, knockout and rescue in Jurkat T cells, and patient-derived primary T cell analysis

   PMID:32098969

   Open questions at the time

   • Scope of affected cargoes beyond TCR not delineated
   • Mechanistic link from individual mutations to specific partner-binding defects not fully mapped
5. 2020 Low

   Whether FCHO1 is post-translationally regulated to influence proliferation was untested; a PKB substrate motif and a peptide that inhibits proliferation implicated FCHO1 phosphorylation in cell-cycle control.

   Evidence Synthetic FCHO1 peptide proliferation assays, xenograft tumor model, and PKB/ERK/SMAD4 pathway readouts

   PMID:32507602

   Open questions at the time

   • No direct demonstration of PKB phosphorylation of endogenous FCHO1
   • No site-specific mutagenesis
   • Link between endocytic function and proliferation not established
6. 2024 Medium

   The molecular logic of CME site initiation was incompletely defined; the yeast ortholog Syp1 was shown to cooperate with CALM/AP180 orthologs to assemble an Eps15-centric initiation complex at lipid- and cargo-enriched membrane.

   Evidence Quantitative live-cell imaging in S. cerevisiae with double/triple mutant genetic epistasis

   PMID:39316607

   Open questions at the time

   • Conservation of the cooperative mechanism in human FCHO1 not directly demonstrated
   • Single ortholog system
7. 2026 Medium

   Whether FCHO1's two domains have distinct functional contributions was unknown; domain-specific rescue of synaptic vesicle endocytosis revealed demand-dependent partitioning, with the F-BAR domain sufficient at low load and the μ-homology domain essential at high load.

   Evidence shRNA knockdown in neurons with pHluorin imaging of SV endocytosis and domain-deletion rescue using shRNA-resistant constructs

   PMID:41943152

   Open questions at the time

   • Molecular basis of high-load dependence on μ-homology domain not defined
   • Generalizability beyond synapses untested

• How FCHO1 curvature sensing, partner decoding, and AP-2 activation are integrated quantitatively at single coated pits across cell types and endocytic demand remains unresolved.
• No unified spatiotemporal model linking F-BAR membrane sensing to μ-homology partner switching
• Phosphoregulation of endogenous FCHO1 unverified